Visual Neuroscience

Research Articles

Increased A-to-I RNA editing of the transcript for GABAA receptor subunit α3 during chick retinal development

HENRIK RINGa1*, HENRIK BOIJEa1*, CHAMMIRAN DANIELa2, JOHAN OHLSONa2, MARIE ÖHMANa2 and FINN HALLBÖÖKa1 c1

a1 Department of Neuroscience, Biomedical Center, Uppsala University, Uppsala, Sweden

a2 Department of Molecular Biology & Functional Genomics, Stockholm University, Stockholm, Sweden

Abstract

Adenosine-to-inosine (A-to-I) RNA editing is a cotranscriptional or posttranscriptional gene regulatory mechanism that increases the diversity of the proteome in the nervous system. Recently, the transcript for GABA type A receptor subunit α3 was found to be subjected to RNA editing. The aim of this study was to determine if editing of the chicken α3 subunit transcript occurs in the retina and if the editing is temporally regulated during development. We also raised the question if editing of the α3 transcript was temporally associated with the suggested developmental shift from excitation to inhibition in the GABA system. The editing frequency was studied by using Sanger and Pyrosequencing, and to monitor the temporal aspects, we studied the messenger RNA expression of the GABAA receptor subunits and chloride pumps, known to be involved in the switch. The results showed that the chick α3 subunit was subjected to RNA editing, and its expression was restricted to cells in the inner nuclear and ganglion cell layer in the retina. The extent of editing increased during development (after embryonic days 8–9) concomitantly with an increase of expression of the chloride pump KCC2. Expression of several GABAA receptor subunits known to mediate synaptic GABA actions was upregulated at this time. We conclude that editing of the chick GABAA subunit α3 transcript in chick retina gives rise to an amino acid change that may be of importance in the switch from excitatory to inhibitory receptors.

(Received December 22 2009)

(Accepted July 07 2010)

(Online publication September 16 2010)

Correspondence:

c1 Address correspondence and reprint requests to: Finn Hallböök, Department of Neuroscience, Biomedical Center (BMC), Uppsala University, Box 593, 751 24 Uppsala, Sweden. E-mail: Finn.hallbook@neuro.uu.se

Footnotes

* These authors contributed equally.